You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
格隆匯港股聚焦(2.19)︱中國人保1月原保費收入降3.57% 中國財險1月份原保費收入跌3.33%
格隆匯 02-19 23:19

【財務數據】

正大企業國際(03839.HK)年度純利跌25.34%至1580萬美元

堡獅龍國際(00592.HK)中期虧損擴大263.86%至9368.7萬港元

【業績預告】

天保能源(01671.HK)預計年度盈利大幅下降60.8%

玖源集團(00827.HK)預期2019年淨虧6.17億元

鱷魚恤(00122.HK):預計中期虧損介乎1.3億至1.8億港元

天虹紡織(02678.HK)預計年度股東應占溢利同比減少25%

威誠國際控股(08107.HK)預計2019年純利降約70%-80%

泰升集團(00687.HK):預計2019年度虧損逾7.5億港元

魯證期貨(01461.HK)預計年度淨利潤下降75%

【運營數據】

中國人保(01339.HK)1月原保費收入下降3.57%至918.57億元

中國財險(02328.HK)1月份原保費收入跌3.33%至525.07億元

中國神華(01088.HK)1月煤炭銷售量增長4.2%至2710萬噸

【股權變更】

艾伯科技(02708.HK)正考慮引入Bit One作為戰略股東

【併購出售】

海通恆信(01905.HK)擬10.08億元出售基礎資產

 微盟集團(02013.HK)擬1.15億元攬雅座在線科技股份63.83%股權 聚焦一站式智慧餐飲解決方案

【增發供股】

協同通信(01613.HK)完成增發8.6億股

環亞國際實業(01143.HK)完成配售11.89億股籌資4140萬港元

【重大事項】

石四藥集團(02005.HK):阿比多爾列入新型冠狀病毒肺炎診療方案(試行第六版)

暢捷通(01588.HK):正式推出雲服務業務新產品暢捷通智+

康哲藥業(00867.HK)捐贈CytoSorb細胞因子吸附器以救治肺炎重症患者

永勝醫療(01612.HK)呼吸濕化治療儀獲藥監局發出醫療器械註冊證

中國鐵建(01186.HK)聯合體中標40.83億元安慶高鐵新區一期項目

中國派對文化(01532.HK):中國工廠已逐漸恢復生產

【回購註銷】

永盛新材料(03608.HK)2月19日耗資386萬港元回購200萬股

康臣藥業(01681.HK)2月19日耗資206.69萬港元回購50萬股

協合新能源(00182.HK)2月19日耗資27.95萬港元回購81萬股

遠東發展(00035.HK)2月19日耗資164萬港元回購48.7萬股

WING ON CO(00289.HK)2月19日耗資163.67萬港元購回7.7萬股

亞洲金融(00662.HK)2月19日耗資80.8萬港元回購21萬股

互太紡織(01382.HK)2月19日耗資119.78萬港元回購25萬股

中國新城(01321.HK)2月19日耗資246.4萬港元回購248萬股

【人事任免】

復宏漢霖-B(02696.HK)委任張文傑為公司總裁

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account